1677P Pancreatic enzyme replacement therapy improves survival in patients receiving nab-paclitaxel plus gemcitabine as first-line treatment for advanced pancreatic adenocarcinoma
| Autor: | Lavacchi, D., Winchler, C., Giommoni, E., Vascotto, I.A., Romano, S., Scolari, F., Taddei, A., Pillozzi, S., Galli, A., Antonuzzo, L. |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S920-S920 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|